Weill Cornell Newsroom > BioPharma Alliances: 2015

BioPharma Alliances: 2015

June 10, 2015 - Weill Cornell Medical College and Cellectis Announce Research Alliance Advancing Drug Discovery and the Translation of Novel Immunotherapies in Leukemia
Weill Cornell Medical College and Cellectis have entered into a strategic translational research alliance to accelerate the development of a targeted immunotherapy for patients with acute myelogenous leukemia, a deadly blood cancer.